Stay updated on Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial
Sign up to get notified when there's something new on the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page.

Latest updates to the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedMelanoma and related MedlinePlus Genetics topics were removed from the page.SummaryDifference0.7%

- Check25 days agoChange DetectedAdded new MedlinePlus Genetics topic: Melanoma. No deletions.SummaryDifference0.2%

- Check32 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference4%

- Check40 days agoChange DetectedUpdated the page from revision v3.0.2 to v3.1.0, indicating a version upgrade with no other content changes.SummaryDifference0.1%

- Check47 days agoChange Detected- Removed MedlinePlus Genetics topic: Melanoma. This reduces the genetics-focused content available on the page, potentially narrowing user access to melanoma-related genetic information.SummaryDifference0.2%

- Check54 days agoChange DetectedAdded Melanoma topic under MedlinePlus Genetics and updated to v3.0.2; removed 'Back to Top' navigation.SummaryDifference0.5%

Stay in the know with updates to Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page.